These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7988012)

  • 1. Metabolic determinants of the course of coronary artery disease in men.
    Watts GF; Mandalia S; Slavin BM; Brunt JN; Coltart DJ; Lewis B
    Clin Chem; 1994 Dec; 40(12):2240-6. PubMed ID: 7988012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS).
    Watts GF; Mandalia S; Brunt JN; Slavin BM; Coltart DJ; Lewis B
    Metabolism; 1993 Nov; 42(11):1461-7. PubMed ID: 8231842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
    Westerveld HT; van Lennep JE; van Lennep HW; Liem AH; de Boo JA; van der Schouw YT; Erkelens DW
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1101-7. PubMed ID: 9672070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
    Gupta R; Vasisht S; Bahl VK; Wasir HS
    Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography.
    Labeur C; De Bacquer D; De Backer G; Vincke J; Muyldermans L; Vandekerckhove Y; Van der Stichele E; Rosseneu M
    Clin Chem; 1992 Nov; 38(11):2261-6. PubMed ID: 1424121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS).
    Watts GF; Lewis B; Brunt JN; Lewis ES; Coltart DJ; Smith LD; Mann JI; Swan AV
    Lancet; 1992 Mar; 339(8793):563-9. PubMed ID: 1347091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Chem Lab Med; 2008; 46(5):667-73. PubMed ID: 18598204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
    Dahlen GH; Guyton JR; Attar M; Farmer JA; Kautz JA; Gotto AM
    Circulation; 1986 Oct; 74(4):758-65. PubMed ID: 2944670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group.
    Watts GF
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S11-9. PubMed ID: 8907209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography.
    Whayne TF; Alaupovic P; Curry MD; Lee ET; Anderson PS; Schechter E
    Atherosclerosis; 1981 Jun; 39(3):411-24. PubMed ID: 6942843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) is a potential coronary risk factor.
    Fujino A; Watanabe T; Kunii H; Yamaguchi N; Yoshinari K; Watanabe Y; Mutou M; Ishikawa S; Ogyuu A; Ashikawa K; Maruyama Y
    Jpn Circ J; 2000 Jan; 64(1):51-6. PubMed ID: 10651207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
    Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
    Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
    Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
    Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.